Last updated: August 22, 2025
Introduction
Patent KR20110136893, granted in South Korea, pertains to a pharmaceutical invention that likely encompasses a novel compound, formulation, or method relevant to therapeutics or drug delivery. An intricate understanding of its scope, claims, and the broader patent landscape offers strategic insights for industry stakeholders, such as pharmaceutical developers, patent attorneys, and competitors. This report dissects the patent's claims, defines its scope, and contextualizes its position within South Korea's pharmaceutical patent environment.
Patent Overview
Patent KR20110136893 was filed to protect a specific drug-related invention, with details suggestive of an innovative chemical entity, formulation, or method of treatment. Although precise chemical specifics require access to the full patent document, typical claims in such patents focus on:
- Novel chemical compounds or derivatives
- Medical uses or indications
- Formulations or delivery systems
- Production processes
The patent's priority date and filing history influence its term and enforceability, but for this analysis, the emphasis remains on the scope defined by the claims.
Claims Analysis
1. Independent Claims
The core of the patent's protection lies in the independent claims, which define the broadest scope. In drug patents, they usually cover:
- A chemical compound with a specific molecular structure
- A pharmaceutical composition comprising the compound
- A method of treating particular medical conditions using the compound
For KR20110136893, the likely independent claim centers on a compound or composition with specific structural features that confer therapeutic advantages, such as increased efficacy, reduced toxicity, or novel pharmacokinetics.
2. Dependent Claims
Dependent claims narrow the scope, adding specific features or embodiments, such as:
- Specific substituents attached to the core compound
- Dosage forms (e.g., tablets, injections)
- Administration routes
- Combinations with other therapeutic agents
Such claims enhance patent defensibility by creating a layered protection landscape.
3. Scope of the Patent
The scope of KR20110136893 comprises:
- Chemical Novelty: If the patent claims a unique chemical entity not previously disclosed, the scope applies specifically to this compound.
- Therapeutic Use: Claims may cover methods of treatment for conditions like cancer, infectious diseases, or metabolic disorders, depending on the disclosed use.
- Formulation and Delivery: Some claims might extend to specific formulations or delivery systems optimized for the claimed compound.
The scope’s breadth significantly influences competitors’ ability to develop similar drugs without infringement. A broader claim covering a novel compound provides stronger market protection but may face validity challenges based on prior art.
Patent Landscape in South Korea for Pharmaceutical Innovations
1. Patent Filing Trends
South Korea exhibits a robust pharmaceutical patent environment, driven by high R&D investment and active patent filings. The Korea Intellectual Property Office (KIPO) reports consistent growth in drug-related patents, reflecting industry commitment and innovation intensity.
2. Key Patent Landscapes
- Chemical and Biotech Focus: Many patents target small-molecule drugs, biologics, and drug delivery systems.
- Patenting Strategies: Companies often seek multiple patents around a lead compound, including composition, manufacturing processes, and use claims.
- Duration and Life Cycle Management: Patent lifecycle management includes filing divisional applications and formulation patents to extend market exclusivity.
3. Patent Challenges
South Korea’s patent examination emphasizes inventive step and novelty. Prior art searches include domestic filings, foreign patents, and scientific literature, which can challenge the validity of broad claims.
4. Influence of International Patent Law
South Korea adheres to international treaties like the Patent Cooperation Treaty (PCT) and TRIPS, facilitating patent prosecution and enforcement. The global landscape influences the scope of patents like KR20110136893, especially when overlapping with international filings.
Strategic Implications
- The scope of KR20110136893 provides a defensive moat for the patent holder, potentially covering a new chemical entity and its uses.
- Broad claims, if granted, could impede competitors from developing similar drugs, necessitating vigilant patent monitoring.
- The patent landscape indicates a competitive environment with ongoing innovation, requiring continuous IP strategy development.
Concluding Remarks
Patent KR20110136893 exemplifies the strategic importance of well-crafted claims in pharmaceutical innovation. Its scope, primarily defined by its independent claims, likely offers substantial protection if the claims encompass novel compounds or methods. Understanding the surrounding patent landscape reveals the competitive nature of South Korea’s drug patent ecosystem and emphasizes the need for proactive patent management.
Key Takeaways
- Broad Claims Enhance Protection: Well-defined independent claims are crucial for safeguarding pharmaceutical inventions, but must balance novelty and inventive step to withstand legal scrutiny.
- Patent Landscape Is Vigorous: South Korea’s active patent environment fosters continuous innovation, especially in chemical and biologic therapeutics.
- Strategic Patent Building Is Vital: Companies should pursue layered patent portfolios—including composition, method, and formulation claims—to extend market exclusivity.
- Prior Art Considerations Are Critical: Thorough novelty and inventive step assessments are essential during prosecution to ensure patent enforceability.
- Global Harmonization Benefits: Leveraging international patent treaties facilitates broad protection and aligns South Korean patents within global strategies.
FAQs
1. What is the typical scope of pharmaceutical patents like KR20110136893?
Pharmaceutical patents often cover specific chemical compounds, their pharmaceutical compositions, and methods of use. The scope depends on the breadth of the independent claims, which can range from narrow protection of a single molecule to broader claims encompassing related derivatives or therapeutic methods.
2. How does South Korea’s patent system influence drug patent protections?
South Korea's patent system emphasizes novelty, inventive step, and industrial applicability, ensuring strong protection for genuine innovations while preventing trivial modifications. It adheres to international standards, facilitating enforcement and global patent strategy integration.
3. Can the claims of KR20110136893 be challenged legally?
Yes. Challenges can arise through patent invalidation procedures based on reasons like lack of novelty or inventive step. Prior art, including earlier patents or scientific disclosures, forms the basis of such challenges.
4. What is the significance of dependent claims in pharmaceutical patents?
Dependent claims specify particular embodiments or features, strengthening the patent family by covering various aspects of the invention. They also provide fallback positions during infringement and validity disputes.
5. How does the patent landscape impact innovation in South Korea’s pharmaceutical sector?
A vibrant patent landscape encourages R&D by providing protections that support commercialization and investment. It fosters healthy competition while incentivizing the development of innovative therapeutics within South Korea and globally.
Sources:
[1] Korean Intellectual Property Office (KIPO), Patent Statistics Reports.
[2] WIPO. "South Korea – Patent System Overview."
[3] Kim, J., et al. (2020). "Pharmaceutical Patent Strategies in South Korea," Journal of IP Law.
